Marsh & McLennan (MMC) Posts Q3 EPS of $0.48, Beats Estimates
More News related to MMC
- In a Tough Year, Employers Hold the Line on Health Benefit Cost Increases - Mercer Survey
- Bank of America Downgrades Insurance Brokers MMC, PGR & AOC
- MMC Issues Statement on Passing of Board Member David A. Olsen
- Multiplied Media and V-ENABLE partner to deliver Poynt2It to U.S. wireless carriers
- Oliver Wyman / Zogby C-Suite Survey Points to Polarized Views on Current Middle East Business Confidence
More News related to Earnings
- Canaccord Adams Maintains a 'Buy' on Protalix BioTherapeutics (PLX); Cerezyme Supply on Track, See More Uplyso EAP Uptake
- Bove Says US Banking System, Dollar to Benefit from Dubai Crisis
- Broadpoint.AmTech Says Solar Inventory Getting Healthier into Year-end
- UBS Maintains a Neutral rating on American Eagle Outfitters (AEO); Lowers Estimates Through 2011
- Barclays Reiterates an 'Overweight' on Deere (DE); Adjusts Estimates & PT
Marsh & McLennan Companies, Inc. (NYSE: MMC) reports Q3 EPS of $0.48, versus the analyst estimate of $0.26. Revenue for the quarter was $2.52 billion, which compares to the estimate of $2.60 billion.
Related Categories
EarningsStocks Mentioned
-0.56Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
